FDA NDC Directory · JSON-LD · Markdown

MARGENZA

NDC 70720-022 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic namemargetuximab-cmkb
Labeler / ManufacturerTerSera Therapeutics LLC
Marketing categoryBiologic License Application · App BLA761150
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsMARGETUXIMAB (25 mg/mL)
Marketing started20210115
Package count0

External sources

Source: openFDA. Public-domain (CC0).